IL2 and cancer: IL-2, IL-12, IL-15, IL-18, and IL-21 could promote NK cells entry into S and G2/M phases of the cell cycle in cancer patients or healthy subjects, and thus have been used to induce ex vivo NK cell proliferation (16, 29–33).